Buy TEFOR DUOTAB (LEVOTHYROXINE SODIUM) Online

Description

Introduction

TEFOR DUOTAB, manufactured by LIBA, is a medication containing levothyroxine sodium as its active substance. It is primarily used for the treatment of hypothyroidism, a condition characterized by an underactive thyroid gland. This description provides an overview of TEFOR DUOTAB, its characteristics, clinical applications, and considerations.

Characteristics

1. Active Substance:
   • TEFOR DUOTAB contains levothyroxine sodium, a synthetic form of thyroxine (T4), the primary hormone produced by the thyroid gland. Levothyroxine sodium is chemically identical to the thyroxine produced naturally in the body and acts as a replacement therapy in patients with hypothyroidism.
2. Formulation:
   • Each tablet of TEFOR DUOTAB is formulated with 100 micrograms of levothyroxine sodium. The tablets are designed for oral administration, providing a convenient and consistent method of delivering the medication.

Clinical Applications

1. Hypothyroidism Treatment:
   • TEFOR DUOTAB is indicated for the treatment of hypothyroidism, a condition characterized by inadequate production of thyroid hormones by the thyroid gland. Levothyroxine sodium supplementation helps restore thyroid hormone levels in the body, alleviating symptoms such as fatigue, weight gain, cold intolerance, dry skin, hair loss, and depression.

Considerations

1. Dosage and Administration:
   • The dosage of TEFOR DUOTAB is individualized based on factors such as the patient’s age, weight, severity of hypothyroidism, and response to treatment. The usual starting dose for adults is 25 to 50 micrograms per day, with gradual dose adjustments based on thyroid function tests and clinical response.
   • TEFOR DUOTAB tablets should be taken orally on an empty stomach, at least 30 minutes to 1 hour before breakfast or other medications. They should be swallowed whole with a full glass of water and not crushed or chewed.
2. Monitoring:
   • Regular monitoring of thyroid function is essential during treatment with TEFOR DUOTAB to ensure optimal dosage adjustments and therapeutic response. Thyroid function tests, including serum thyroid-stimulating hormone (TSH) levels, should be performed periodically to assess thyroid hormone levels and adjust the dosage accordingly.
3. Adverse Effects:
   • Adverse effects associated with TEFOR DUOTAB are rare when used at appropriate dosages. However, excessive dosage or rapid dose adjustments may lead to symptoms of hyperthyroidism, including palpitations, rapid heartbeat, sweating, tremors, and weight loss. Adverse effects such as headache, insomnia, nervousness, and gastrointestinal disturbances may also occur, particularly during the initial stages of treatment or with dosage adjustments.
4. Contraindications:
   • TEFOR DUOTAB is contraindicated in individuals with hypersensitivity to levothyroxine sodium or any of the tablet’s components. It should not be used in patients with untreated thyrotoxicosis (hyperthyroidism) or adrenal insufficiency. Caution is advised in patients with cardiovascular disease, diabetes mellitus, or severe hypothyroidism, as dosage adjustments may be necessary to prevent adverse effects or interactions with other medications.

Conclusion

TEFOR DUOTAB, containing levothyroxine sodium as its active substance, is an essential medication for the treatment of hypothyroidism. By supplementing thyroid hormone levels in the body, it helps alleviate symptoms and restore metabolic balance in patients with thyroid hormone deficiency. However, its use requires careful monitoring and individualized dosage adjustments to achieve optimal therapeutic outcomes. Consultation with a qualified healthcare provider is essential to determine the appropriate use of TEFOR DUOTAB and to minimize potential risks.